If you enjoy this content, please share it with a colleague
RELATED CONTENT
Advances in digital mammography are evolving as clinicians look to improve breast cancer screening in women. In recent years, new technological trends have emerged; notably, the addition of 3-D breast imaging, or tomosynthesis, which was approved by the U.S. Food and Drug Administration (FDA) in 2011. But as technology improves, questions remain over the recommended frequency of screening for breast cancer.
Planmed Verity is designed to find subtle extremity fractures during the first visit to the clinic — the types of fractures that have most commonly been missed when only using 2-D radiographs. Planmed Verity Extremity Scanner is a unique solution to the problem; it provides fast 3-D imaging at the point of care. It is intended for pre- and postoperative imaging, and it has better resolution and patient adaptability and uses a significantly lower dose of radiation than full-body computed tomography (CT). Unlike any other 3-D imaging device, Planmed Verity also allows for weight-bearing imaging of the extremities.
October 5, 2011 — The U.S. Food and Drug Administration (FDA) has issued 510(k) approval for Planmed’s Nuance Excel full-field digital mammography (FFDM) system. The system includes the company’s proprietary MaxView Breast Positioning System for enhanced tissue visibility, and Side Access patient positioning for optimal working ergonomics.
Planmed Oy introduces Planmed Verity, a new mobile computed tomography (CT) scanner for orthopedic imaging of the extremities. The Planmed Verity is a low-dose imaging system that provides fast and accurate 3-D imaging of peripheral skeletal fractures and disorders at the point-of-care. The compact device can be easily sited in any existing X-ray room, side-by-side with other imaging systems.
The Planmed Nuance Excel FFDM unit (currently not FDA approved) boasts proprietary TriFilter technology with the new Tungsten X-ray tube, designed to reduce levels of radiation during a digital mammography exam. This new technology uses less than 60 percent of the dose normally used in conventional digital mammography.